From: Effects of specific allergen immunotherapy on biological markers and clinical parameters in asthmatic children: a controlled-real life study
Asthma
FeNO (>12 years) (ppb)
FeNO(<12 years) (ppb)
Control asthma
<25
<20
Intermediate
25–30
Non-control asthma
>50
>35